ArticleNeurological research and practice2023

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.

Sabine Seidel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.